You are here

SL-701

Stemline Therapeutics Announces the Presentation of Clinical Trial Results With a Synthetic Peptide Vaccine for Brain Cancer, Now Being Developed as SL-701, at the Society of Neuro-Oncology (SNO) Annual Meeting

Yahoo/Globe Newswire

Sat, 11/23/13 - 12:37 pm

Stemline Therapeutics

Stemline Therapeutics gains ground after saying it will report data on cancer therapy

Yahoo/AP

Tue, 11/19/13 - 12:32 pm